The Optimizing HIV Treatment Access (OHTA) Initiative (2012—2017), funded by Sweden and Norway through UNICEF, supported the scale-up of lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women living with HIV. The project focused on four countries with a high HIV burden: Côte d’Ivoire, the Democratic Republic of the Congo, Malawi and Uganda. OHTA aimed to strengthen health systems to deliver lifelong treatment (also known as ‘Option B+’) for pregnant women and breastfeeding mothers living with HIV.
The three objectives of OHTA were:
- More effective delivery of treatment for pregnant women and mothers living with HIV by strengthening the capacity of the primary health-care system;
- Increase demand timely utilization and retention rates in prevention of mother-to-child transmission (PMTCT) services;
- Strengthening monitoring and evaluation (M&E) efforts to improve health service delivery for pregnant and breastfeeding women living with HIV and their children.